Studies on the antiobesity effect of zinc-α 2-glycoprotein in the ob/ob mouse

International Journal of Obesity

Volumn 35, Issue 3, 2011, Pages 345-354

  Russell, S T ^a   Tisdale, M J ^a  

^a ASTON UNIVERSITY   (United Kingdom)

Author keywords

adipose triglyceride lipase; extracellular signal regulated kinase; hormone sensitive lipase; lipolysis; zinc a2 glycoprotein

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ADIPOSE TRIGLYCERIDE LIPASE; ANTIOBESITY AGENT; HORMONE SENSITIVE LIPASE; ISOPRENALINE; MITOGEN ACTIVATED PROTEIN KINASE; TRIACYLGLYCEROL LIPASE; UNCLASSIFIED DRUG; ZINC ALPHA2 GLYCOPROTEIN;

ADIPOCYTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; BROWN ADIPOSE TISSUE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG MECHANISM; DRUG TISSUE LEVEL; EPIDIDYMIS FAT; FLUID INTAKE; FOOD INTAKE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INTRAABDOMINAL FAT; LIPOLYSIS; MALE; MOUSE; NONHUMAN; OBESITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECTUM TEMPERATURE; SUBCUTANEOUS FAT; UPREGULATION;

ADIPOCYTES; ADIPOSE TISSUE; ADIPOSITY; ANIMALS; ANTI-OBESITY AGENTS; CARRIER PROTEINS; LIPASE; LIPOLYSIS; MALE; MICE; MICE, OBESE; OBESITY; SEMINAL PLASMA PROTEINS; STEROL ESTERASE;

ANIMALIA; MUS;

EID: 79952696498     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2010.150     Document Type: Article

References (43)

1. Rössner S. Obesity: the disease of the twenty-first century. Int J Obes Relat Metab Disord 2002; 26 (Suppl 4): S2-S4. (Pubitemid 36071962)
2. Kahn SE, Hull RL, Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 2006; 444: 840-846. (Pubitemid 46024990)
3. 2-glycoprotein. Biochim Biophys Acta 2004; 1636: 59-68. (Pubitemid 38231005)
4. Hirai K, Hussey HJ, Barber MD, Price SA, Tisdale MJ. Biological evaluation of a lipid-mobilising factor isolated from the urine of cancer patients. Cancer Res 1998; 58: 2359-2365. (Pubitemid 28252695)
5. Todorov PT, McDevitt TM, Meyer DJ, Ueyama H, Ohkubo I, Tisdale MJ. Purification and characterisation of a tumor lipid-mobilizing factor. Cancer Res 1998; 58: 2353-2358. (Pubitemid 28252694)
6. Bing C, Bao Y, Jenkins J, Sanders P, Manieri M, Cinti S et al. Zinc-a2-glycoprotein, a lipid mobilizing factor, is expressed in adipocytes and is upregulated in mice with cancer cachexia. Proc Natl Acad Sci USA 2004; 101: 2500-2505. (Pubitemid 38269340)
7. Dahlman I, Kaaman M, Olsson T, Tan GD, Bickerton AST, Wahlén K et al. A unique role of monocyte chemoattractant protein 1 among chemokines in adipose tissue of obese subjects. J Clin Endocrinol Metab 2005; 90: 5834-5840. (Pubitemid 41415500)
8. 2-glycoprotein is involved in regulation of body weight through inhibition of lipogenic enzymes in adipose tissue. Int J Obes 2009; 33: 1023-1030.
9. 2-glcyoprotein is downregulated with fat mass expansion in obesity. Clin Endocrinol 2010; 72: 334-341.
10. Rolli V, Radosavljevic M, Astier V, Macquin C, Castan-Laurell I, Visentin V et al. Lipolysis is altered in MHC class 1 zinc-a2-glycoprotein deficient mice. FEBS Lett 2007; 581: 394-400. (Pubitemid 46157227)
11. Jocken JWE, Goosens GH, van Hees AMJ, Frayn KN, van Baak M, Stegen J. Effect of beta-adrenergic stimulation on whole-body and abdominal subcutaneous adipose tissue lipolysis in lean and obese men. Diabetologica 2008; 51: 320-327.
12. Hellstrom L, Langin D, Reynisdottir S, Dauzats M, Arner P. Adipocyte lipolysis in normal weight subjects with obesity among first-degree relatives. Diabetologica 1996; 39: 921-928. (Pubitemid 26249111)
13. Jocken JWE, Blaak EE. Catecholamine-induced lipolysis in adipose tissue and skeletal muscle in obesity. Physiol Behav 2008; 94: 219-230. (Pubitemid 351615431)
14. 2-glycoprotein-1 a candidate gene for obesity? Diabetes 2003; 52: 2175-2181. (Pubitemid 36919814)
15. 2-glyco-protein (ZAG) in ob/ob mice. Endocrinol 2010; 151: 948-957.
16. Russell ST, Hirai K, Tisdale MJ. Role of b3-adrenergic receptors in the action of a tumour lipid mobilizing factor. Br J Cancer 1992; 86: 424-428.
17. Bailey CJ, Flatt PR, Atkins TW. Influence of genetic background and age on the expression of the obese hyperglycaemic syndrome in Aston ob/ob mice. Int J Obes 1982; 6: 11-21. (Pubitemid 12157286)
18. Beck SA, Tisdale MJ. Production of lipolytic and proteolytic factors by a murine tumor-producing cachexia in the host. Cancer Res 1987; 47: 5919-5923. (Pubitemid 18018730)
19. Wieland O. Glycerol UV method. In: Bergemeyer HU (ed). Methods of Enzymatic Analysis. Academic Press: London, UK, 1974, pp 1404-1409.
20. Lyon I, Ookhtens M, Montisano D, Baker N. Fat pad triacylgly-cerol fatty acid mobilisation and oxidation in starving mice. Biochim Biophys Acta 1988; 958: 188-195.
21. Mulligan HD, Beck SA, Tisdale MJ. Lipid metabolism in cancer cachexia. Br J Cancer 1992; 66: 57-61.
22. Stansbie D, Brownsey RW, Crettaz M, Denton RM. Acute effects in vivo of anti-insulin serum on rates of fatty acid synthesis and activities of acetyl-coenzyme A carboxylase and pyruvate dehydrogenase in liver and epididymal adipose tissue of fed rats. Biochem J 1976; 160: 413-420.
23. Kultz D, Madhany S, Burg MB. Hyperosmolality causes growth arrest of murine kidney cells. Induction of GADD45 and GADD153 by osmo-sensing via stress-associated protein kinase 2. J Biol Chem 1998; 273: 13645-13651. (Pubitemid 28268409)
24. 2-glycoprotein (ZAG) on expression of uncoupling proteins in skeletal muscle and adipose tissue. Cancer Lett 2004; 212: 71-81. (Pubitemid 38887722)
25. Susulic VS, Frederick RC, Lawitts J, Tozze E, Kahn BB, Harper ME et al. Targeted disruption of the b3-adrenergic receptor gene. J Biol Chem 1995; 270: 29483-29492.
26. Day C, Bailey CJ. Effect of the antiobesity agent sibutramine in obese-diabetic ob/ob mice. Int J Obese 1998; 22: 619-623. (Pubitemid 28312770)
27. Stejskal D, Karpisek M, Reutova H, Stejskal P, Kotolova H, Kollar P. Determination of serum zinc-alpha-2-glycoprotein in patients with metabolic syndrome by a new ELISA. Clin Biochem 2008; 41: 313-316.
28. Bondar OP, Barnidge DR, Klee EW, Davis BJ, Klee GG. LC-MS/MS quantification of Zn-a2-glycoprotein: a potential serum biomar-ker for prostate cancer. Clin Chem 2007; 53: 673-678. (Pubitemid 46580237)
29. Mori S, Nojiri H, Yoshizuka N, Takema Y. Rapid desensitization of lipolysis in visceral and subcutaneous adipocytes of rats. Lipids 2007; 42: 307-314. (Pubitemid 46668926)
30. Tavernier G, Galitzky J, Valet P, Remaury A, Bouloumie A, Lafontan M et al. Molecular mechanisms underlying regional variations of catecholamine-induced lipolysis in rat adipocytes. Am J Physiol Endocrinol Metab 1995; 31: E1135-E1142.
31. Morimoto C, Kameda K, Tsujita T, Okuda H. Relationships between lipolysis induced by various lipolytic agents and hormone-sensitive lipase in rat fat cells. J Lipid Res 2001; 42: 120-127. (Pubitemid 32142867)
32. Greenberg AS, Shen WJ, Muliro K, Patel S, Sruza SC, Roth RA et al. Stimulation of lipolysis and hormone-sensitive lipase via the extracellular signal-related kinase pathway. J Biol Chem 2001; 276: 45456-45461.
33. Wu JJ, Roth RJ, Anderson EJ, Hong E-G, Lee M-K, Choi CS et al. Mice lacking MAP kinase phosphatase-1 have enhanced MAP kinase activity and resistance to diet-induced obesity. Cell Metab 2006; 4: 61-73. (Pubitemid 43942257)
34. Agustsson T, Ryden M, Hoffstedt J, Van Harmelen V, Dicker A, Laurencikiene J et al. Mechanism of increased lipolysis in cancer cachexia. Cancer Res 2007; 67: 5531-5537. (Pubitemid 46997295)
35. Haemmerle G, Lass A, Zimmerman R, Gorkiewicz G, Meyer C, Rozman J et al. Defective lipolysis and altered energy metabolism in mice lacking adipose triglyceride lipase. Science 2006; 312: 734-737.
36. Steinburg GR, Kemp BE, Watt MJ. Adipocyte triglyceride lipase expression in human obesity. Am J Physiol Endocrinol Metab 2007; 293: E958-E964. (Pubitemid 47535826)
37. Berndt J, Kralisch S, Kloting N, Ruschke K, Kern M, Fasshauer M et al. Adipose triglyceride lipase gene expression in human visceral obesity. Exp Clin Endocrinol Diabetes 2008; 116: 203-210. (Pubitemid 351600581)
38. Jocken JWE, Langin D, Smit E, Saris WHM, Valle C, Hul GB et al. Adipose triglyceride lipase and hormone-sensitive lipase protein expression is decreased in the obese insulin-resistant state. J Clin Endocrinol Metab 2007; 92: 2292-2299. (Pubitemid 46997136)
39. 2-glycoprotein expression in adipose tissue in cancer cachexia. Br J Cancer 2005; 92: 876-881. (Pubitemid 40462633)
40. 2-glycoprotein, a lipid mobilizing factor, is expressed and secreted by human (SGBS) adipocytes. FEBS Lett 2005; 579: 41-47. (Pubitemid 40023371)
41. 2-glycoprotein in adipose tissue and liver of obese ob/ob mice and by tumour necrosis factor-a in adipocytes. J Endocrinol 2010; 204: 165-172.
42. Gettys TW, Ramkumar V, Uhing RJ, Singer L, Taylor IL. Alterations in mRNA levels, expression and function of GTP-binding regulatory proteins in adipocytes from obese mice (C57BL/6J-ob/ob). J Biol Chem 1991; 266: 15949-15955. (Pubitemid 21907749)
43. Islam-Ali B, Khan S, Price SA, Tisdale MJ. Modulation of adipocyte G-protein expression in cancer cachexia by a lipid-mobilizing factor (LMF). Br J Cancer 2001; 85: 758-762.